In recent years there has been growing interest in the use of vasopressin as an adjunctive vasopressor in septic shock. This review article aims to summarise the rationale for its use, review the evidence of its effects in clinical studies and consider future areas of research.
BarrettLKSingerMClappLH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med2007;35: 33–40.
2.
LandryDWLevinHRGallantEM. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation1997;95: 1122–25.
3.
SharsharTBlanchardAPaillardM. Circulating vasopressin levels in septic shock. Crit Care Med2003;31: 1752–58.
4.
SharsharTCarlierRBlanchardA. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med2002;30: 497–500.
5.
PatelBMChittockDRRussellJAWalleyKR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology2002;96: 576–82.
6.
LauzierFLevyBLamarrePLesurO. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med2006;32: 1782–89.
7.
RussellJAWalleyKRSingerJ. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med2008;358: 877–87.
8.
GordonACRussellJAWalleyKR. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med2010;36: 83–91.
9.
HolmesCLWalleyKRChittockDR. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med2001;27: 1416–21.
10.
TorgersenCDunserMWWenzelV. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial. Intensive Care Med2010;36: 57–65.
11.
RussellJAWalleyKRGordonAC. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med2009;37: 811–18.
12.
AnnaneD. Vasopressin plus corticosteroids: the shock duo!Crit Care Med2009;37: 1126–27.
13.
AguileraGRabadan-DiehlC. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept2000;96: 23–29.
14.
KuwaharaSArimaHBannoR. Regulation of vasopressin gene expression by cAMP and glucocorticoids in parvocellular neurons of the paraventricular nucleus in rat hypothalamic organotypic cultures. J Neurosci2003;23: 10231–37.
15.
LauandFRuginskSGRodriguesHL. Glucocorticoid modulation of atrial natriuretic peptide, oxytocin, vasopressin and Fos expression in response to osmotic, angiotensinergic and cholinergic stimulation. Neuroscience2007;147: 247–57.
16.
KimJKSummerSNWoodWMSchrierRW. Role of glucocorticoid hormones in arginine vasopressin gene regulation. Biochem Biophys Res Commun2001;289: 1252–26.
17.
ErtmerCBoneHGMorelliA. Methylprednisolone reverses vasopressin hyporesponsiveness in ovine endotoxemia. Shock2007;27: 281–88.
18.
BauerSRLamSWChaSSOyenLJ. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study. J Crit Care2008;23: 500–06.
19.
WalleyKRGordonACRussellJA. Hemodynamic effects of vasopressin versus norepinephrine in the VASST cohort. Am J Respir Crit Care Med2007;175: A594.
20.
LucknerGDunserMWJochbergerS. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med2005;33: 2659–66.
21.
DunserMWMayrAJUlmerH. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg2001;93: 7–13.
22.
DunserMWMayrAJUlmerH. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation2003;107: 2313–19.
23.
van HarenFMRozendaalFWvan der HoevenJG. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest2003;124: 2256–60.
24.
HolmesCLLandryDWGrantonJT. Science review: Vasopressin and the cardiovascular system part 1–receptor physiology. Crit Care2003;7: 427–34.
25.
HaslamRJRossonGM. Aggregation of human blood platelets by vasopressin. Am J Physiol1972;223: 958–67.
26.
MehtaSGrantonJCookD. Troponin and CKMB trends in patients with septic shock randomized to vasopressin (VP) or Norepinephrine (NE). Am J Respir Crit Care Med2009;179: A1564.
27.
GordonACMehtaSLapinskyS. Comparison of vasopressinversus norepinephrine-associated ischemic ECG changes in septic shock. Intensive Care Med2009;35: S114.
28.
GordonAC. ICS Research Prioritisation Exercise 2008; VAsopressin versus Noradrenaline as Initial therapy in Septic sHock. JICS2009;10: 72–73.
